ETRI-Knowledge Sharing Plaform

KOREAN
논문 검색
Type SCI
Year ~ Keyword

Detail

Journal Article 신규 약물 설계를 위한 인공지능 기술 동향
Cited - time in scopus Download 58 time Share share facebook twitter linkedin kakaostory
Authors
한영웅, 정호열, 박수준
Issue Date
2023-06
Citation
전자통신동향분석, v.38, no.3, pp.38-46
ISSN
1225-6455
Publisher
한국전자통신연구원
Language
Korean
Type
Journal Article
DOI
https://dx.doi.org/10.22648/ETRI.2023.J.380305
Abstract
The value of living a long and healthy life without suffering has increased owing to aging populations, transition to welfare societies, and global interest in health deriving from the novel coronavirus disease pandemic. New drug development has gained attention as both a tool to improve the quality of life and high-value market, with blockbuster drugs potentially generating over 10 billion dollars in annual revenue. However, for newly discovered substances to be used as drugs, various properties must be verified over a long period in a time-consuming and costly process. Recently, the development of artificial intelligence technologies, such as deep and reinforcement learning, has led to significant changes in drug development by enabling the effective identification of drug candidates that satisfy desired properties. We explore and discuss trends in artificial intelligence for de novo drug design.
KSP Keywords
De novo drug design, Desired properties, High-value, Long period, New Drug Development, Quality of life, Reinforcement Learning(RL), Various properties, aging population, artificial intelligence
This work is distributed under the term of Korea Open Government License (KOGL)
(Type 4: : Type 1 + Commercial Use Prohibition+Change Prohibition)
Type 4: